Andrew N. Schiff, Director at Aclaris Therapeutics, Inc. (ACRS), sold 39,130 shares at $15.14 ($592K) on 2022-06-17, disclosed to the SEC on 2022-06-21.
Open-market sale of $592k ACRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.14 | 19,565 | $296K | 50.0% |
| 2 | $15.14 | 19,565 | $296K | 50.0% |
| Total | $15.14 avg | 39,130 | $592K | 100% |
| Filing → |
| ACRS | SELL | 2022-10-19 | $1.7M | — | Filing → |
| ACRS | SELL | 2022-10-11 | $237K | — | Filing → |
| ACRS | SELL | 2022-10-06 | $1.5M | — | Filing → |